Under the Therapeutic Goods Act 1989, the control of medicinal products for human use is controlled by the issue of Marketing Authorisations.
In Australia, the Therapeutic Goods Administration (TGA) is responsible for issuing Marketing Authorisations. The TGA reviews all licence applications to ensure that the medical gases are safe for patient use, efficacious, covering all of the proposed indications and manufactured to the appropriate levels of quality. Where applicable, the medical gases (and their component gases) comply with the relevant European Pharmacopoeia monographs.
For more information on BOC's Marketing Authorisations, please refer to the Australian Register of Therapeutic Goods.